We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KTB:NYSEKontoor Brands, Inc. Analysis

Data as of 2026-05-19 - not real-time

$64.25

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Kontoor Brands (KTB) is trading at $64.25, well below its DCF-derived fair value of $109.33, indicating a substantial undervaluation. The company delivers robust fundamentals, highlighted by a 45% revenue growth rate, a 53% return on equity, and a solid 3.3% dividend yield with a modest 42% payout ratio, suggesting dividend sustainability. Technicals are mixed: the 20‑day SMA ($71.07) sits above the current price, the MACD histogram is negative and the RSI at 40 points to neutral momentum, while volume is trending higher. Recent strategic news—divesting the Lee brand to concentrate on Wrangler and Helly Hansen—could sharpen focus and improve margins, but may introduce short‑term execution risk. Given the low beta of 0.93 on the exchange, moderate sector volatility (56% 30‑day), and a market cap of $3.55 B, the stock presents a compelling blend of growth and value attributes for investors willing to tolerate medium‑term uncertainty.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and neutral RSI suggest limited upside in the next few weeks
  • Current price remains above the identified support level of $61.69
  • Divestiture of the Lee brand may cause short‑term execution volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to DCF fair value and forward PE of ~9.9
  • Strong revenue growth, high ROE, and sustainable dividend yield
  • Strategic focus on Wrangler and Helly Hansen expected to improve margins

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term upside potential of ~44% versus fair value
  • Consistently high profitability metrics (gross margin ~48%, operating margin ~17%)
  • Dividend yield of 3.3% with a comfortable payout ratio supporting income investors

Key Metrics & Analysis

Financial Health

Revenue Growth45.00%
Profit Margin8.29%
P/E Ratio13.0
ROE53.22%
ROA15.70%
Debt/Equity206.08
P/B Ratio6.3
Op. Cash Flow$424.4M
Free Cash Flow$204.8M

Technical Analysis

TrendNeutral
RSI40.1
Support$61.69
Resistance$84.99
MA 20$71.07
MA 50$70.49
MA 200$71.24
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$109.33
Target Price$92.67
Upside/Downside44.23%
GradeUndervalued
TypeBlend
Dividend Yield3.30%

Risk Assessment

Beta1.14
Volatility56.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.